EPCAM and retinoblastoma: The EGP2-TK-2T transfected retinoblastoma cell lines treated with GCV drug showed the apoptotic marker, activated Caspase3 and necrotic marker PARP-1 expression (Figure 6C, lanes 3, 4) but not in normal cell lines (Figure 6C, lanes 1, 2).